iZafe Group
12.10.2021 09:01:48 CEST | ACCESS Newswire | Press release
STOCKHOLM, SE / ACCESSWIRE / October 12, 2021 / iZafe Group (STO:IZAFE-B)
iZafe Group AB (publ) ("iZafe" or "the Company") announces that Vice Chairman of the Board Göran Hermansson and CEO Anders Segerström are subscribing for an additional of combined 458,000 units in the ongoing rights issue of units (" The Rights Issue"), which was announced and communicated through press release on September 6, 2021. An EU-growth prospect containing the full terms for the Rights Issue was announced and communicated through press release on September 24, 2021.
Today, the Company announces that Göran Hermansson and Anders Segerström will subscribe for a total of 458,000 units, corresponding to SEK 687,000.00 SEK. Göran Hermansson subscribes for 324,667 units, corresponding to SEK 487,000.50. Anders Segerström subscribes for 133,333 units, corresponding to SEK 199,999.50, in addition to his existing subscription commitment of SEK 315,046.50. Anders Segerström has received unit rights from Göran Hermansson in order to subscribe with preferential rights. This means that the Board of Directors and management have subscribed for a total of 876,149 units, corresponding to SEK 1,314,223.50 in the ongoing Rights Issue.
Subscription commitment and underwriting commitments
The Rights Issue is already covered to approximately 18 percent through subscription commitments and to approximately 82 percent through underwriting commitments. In total, 100 percent of the Rights Issue is thus covered by subscription commitments and underwriting commitments before Anders Segerström and Göran Hermansson's additional subscriptions.
The subscription commitments have been made by a number of existing shareholders in the Company (by, among others, Chairman of the Board Joachim Källsholm, Board member Richard Wolff, CEO Anders Segerström, CFO Ida Almgren, Sales Manager Tobias Johansson, former Chairman of the Board Carl Johan Merner and the Company's founders Göran Sjönell and Sten Röing) as well as external investors.
Important dates for the Rights Issue
Trading in unit rights on Nasdaq First North Premier Growth Market: October 4 - October 13, 2021
Subscription period for the Rights Issue: October 4 - October 18, 2021
Estimated date for publication of issue results: October 21, 2021
Advisors
Mangold Fondkommission AB is the financial advisor to iZafe in connection with the Rights Issue. Eversheds Sutherland Advokatbyrå AB is the legal advisor to the Company in connection with the Rights Issue.
Contacts
Anders Segerström, Chief Executive Officer
E-mail: anders.segerstrom@izafegroup.com
Phone number: +46 70-875 14 12
iZafe Group AB (publ.)
Södra Fiskartorpsvägen 20
114 33 Stockholm
E-mail: ir@izafegroup.com
www.izafe.se/investor-relations/
About Us
iZafe Group is a Swedish Life-Science company that develops and markets medical and digital security solutions to create safer drug handling at home. The company's digital medication dispenser Dosell reduces the risk of incorrect medication, increases security for family and relatives and relieves public care personnel. The products form a holistic concept that facilitates patient medication and gives those who are treated at home better conditions for a happy and safe life. Customers today consist of public and private care providers in Sweden, the Nordic countries and globally. iZafe Group sells primarily through well-established partners who already have long and deep customer relationships with the priority customer groups. The head office is located in Stockholm.
The company is listed on the NASDAQ First North Premier Growth Market. FNCA Sweden AB is the company's Certified Adviser. Phone: +46 (0) 8 528 00 399. E-mail: info@fnca.se . Further information is available at www.izafe.se/investor-relations/ .
Attachments
Board member and the CEO of iZafe subscribe for an additional 458,000 units in ongoing rights issue
SOURCE: iZafe Group
View source version on accesswire.com:
https://www.accesswire.com/667692/Board-Member-and-The-CEO-of-iZafe-Subscribe-for-an-Additional-458000-Units-in-Ongoing-Rights-Issue
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Eudia Accelerates Enterprise AI Transformation with Google Cloud's Gemini Enterprise for Legal25.8.2026 15:50:00 CEST | Press release
PALO ALTO, CA / ACCESS Newswire / August 25, 2026 / Eudia, the augmented intelligence platform for enterprise legal, contracting, and compliance, today announced a partnership with Google to launch new industry-specific AI capabilities on Google Cloud's Gemini Enterprise for Legal. Eudia's agent scales the legal, contracting, and compliance expertise of an organization's top operators to every team in the enterprise. Built on Google's Agent Development Kit and connected via MCP, Eudia combines a suite of specialized agents with digital twins of domain-scoped institutional knowledge, orchestrated with legal-specific reasoning and access to legal databases. Eudia enables Legal, Compliance, Procurement, and Revenue teams to draft and review contracts, analyze marketing assets for compliance, assess risk across thousands of executed contracts, and manage obligations across the entire company portfolio, giving large enterprises a faster path to trusted, governed legal AI. In practice, this
Envision Pharma Group Names Ryan Tubbs, Senior Vice President, Commercial Growth25.8.2026 15:00:00 CEST | Press release
New role unifies sales enablement, lead generation, and marketing under centralized leadership and expands oversight to customer success, supporting a consistent, connected client experience across Envision. FAIRFIELD, CT / ACCESS Newswire / August 25, 2026 / Envision Pharma Group (Envision) has appointed Ryan Tubbs as Senior Vice President, Commercial Growth. In this newly created role, Tubbs will lead the centralized Commercial Growth function spanning sales enablement, lead generation, marketing, and client success. He will also help shape Envision's commercial strategy and operating model to accelerate enterprise growth. Tubbs' remit also includes the Client Implementation and Client Experience teams. Connecting Envision's pre-sale and post-sale capabilities will create a more integrated commercial engine, making it easier for teams to bring the best of Envision to clients and for clients to realize value quickly. The timing is notable as Envision's iEnvision®, market access, and m
Polaris Renewable Energy Announces Renewal of Normal Course Issuer Bid25.8.2026 13:50:00 CEST | Press release
TORONTO, ON / ACCESS Newswire / August 25, 2026 / Polaris Renewable Energy Inc. (TSX:PIF) ("Polaris" or the "Company") today announced that the Toronto Stock Exchange ("TSX") has accepted its notice of intention to renew its normal course issuer bid ("NCIB"). The Company's Board of Directors believes that an NCIB represents an appropriate and desirable use of its available free cash to increase shareholder value and is in the best interest of the Company and its shareholders. Pursuant to the notice, Polaris may purchase up to 2,021,205 of its common shares ("Shares"), representing approximately 10% of the public float of 20,212,059 Shares as at August 13, 2026, during the twelve month period commencing August 27, 2026 and ending August 26, 2027, provided that the board of directors of Polaris has initially limited the NCIB to repurchase up to 176,872 Shares. As at August 13, 2026, there were 20,895,285 Shares issued and outstanding. Under the NCIB, other than purchases made under block
IXOPAY Appoints Ajoy Krishnamoorthy as CEO to Accelerate Growth and Advance Payments for the Agentic Age25.8.2026 12:00:00 CEST | Press release
Enterprise Software and Commerce Leader Will Guide IXOPAY's Next Development Phase of Its Unified, AI-Native Payments Infrastructure Platform DALLAS, TX / ACCESS Newswire / August 25, 2026 / IXOPAY, the payment infrastructure solution that enables fluid commerce, today announced the appointment of Ajoy Krishnamoorthy as CEO. Krishnamoorthy brings more than two decades of enterprise software leadership and extensive product engineering experience turning complex technologies into platforms that businesses depend on to grow. Krishnamoorthy joins IXOPAY at a pivotal moment, as it helps unlock fluid commerce for enterprise merchants. Krishnamoorthy will focus on bringing IXOPAY's modular product suite into the agentic age, providing merchants with the freedom to buy what they need and build what they want in scaling their global payment operations. He comes with a customer-first mindset, ensuring momentum is maintained, and support is given to customers during this seismic shift in the lan
LiberNovo Support Week Goes Live: Up to 44% Off on Maxis, Omni SE and Omni Pro Ergonomic Chair Series25.8.2026 09:00:00 CEST | Press release
HONG KONG, HK / ACCESS Newswire / August 25, 2026 / LiberNovo Support Week is now open across the European Union and the United Kingdom. Through September 8, the Maxis Series, Omni SE, and Omni Pro are up to 44% off in the EU and up to 39% off in the UK, with three gift tiers and triple points for members. The name works two ways. Support your body. LiberNovo chairs respond as you lean in, sit upright, and recline, instead of holding you to one fixed posture. Support your journey. Through Create for Creators, LiberNovo backs the developers, designers, streamers, and gamers who do their work seated. Maxis Series: Built for Bigger Builds The event leads with the Maxis Series, sized from the frame up for taller, broader, and heavier users. A 52 cm seat depth supports more of the thigh, the wider cushion leaves room to shift, and the reinforced structure is rated to 181 kg. Five-stage recline control runs from 105° to 160° on progressive springs, so support holds steady at every angle, inc
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom